Two neglected disease deals signed with Merck & Co and university
This article was originally published in Scrip
Executive Summary
The not-for-profit body, the Drugs for Neglected Diseases initiative (DNDi), which has an annual budget of about €25 million a year, has signed two separate deals to identify new medicines to treat neglected tropical diseases.